Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party.
Sculier JP, Klastersky J, Libert P, Ravez P, Thiriaux J, Lecomte J, Bureau G, Vandermoten G, Dabouis G, Michel J, et al. Sculier JP, et al. Among authors: michel j. Ann Oncol. 1990;1(2):128-33. doi: 10.1093/oxfordjournals.annonc.a057690. Ann Oncol. 1990. PMID: 1964073 Free article. Clinical Trial.
Phase II trial with chlorozotocin in advanced colorectal cancer.
Bleiberg H, Rozencweig M, Michel J, Clavel M, Longeval E, Feremans W, Bondue H, Lardinois J, Crespeigne N, Kenis Y. Bleiberg H, et al. Among authors: michel j. Eur J Cancer Clin Oncol. 1981 Aug;17(8):863-6. doi: 10.1016/0014-2964(81)90306-6. Eur J Cancer Clin Oncol. 1981. PMID: 6459936 No abstract available.
Combination of dacarbazine and mitomycin in advanced colorectal cancer.
Bleiberg H, Clavel M, Nicaise C, Devriendt J, Michel J, Vanderlinden B, Rozencweig M. Bleiberg H, et al. Among authors: michel j. Cancer Chemother Pharmacol. 1982 Dec;10(1):68-9. doi: 10.1007/BF00257242. Cancer Chemother Pharmacol. 1982. PMID: 7160047
Phase Ii trial of fotemustine in advanced colorectal cancer.
Bleiberg H, Becquart D, Michel J, Cavalli F, Gerard B. Bleiberg H, et al. Among authors: michel j. Eur J Cancer. 1990;26(11-12):1260-1. doi: 10.1016/0277-5379(90)90281-w. Eur J Cancer. 1990. PMID: 2150002 No abstract available.
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions.
Ferreira Filho AF, Di Leo A, Paesmans M, Beauduin M, Vindevoghel A, Michel J, Focan C, Awada A, Cardoso F, Dolci S, Bartholomeus S, Piccart MJ. Ferreira Filho AF, et al. Among authors: michel j. Ann Oncol. 2002 Mar;13(3):416-21. doi: 10.1093/annonc/mdf051. Ann Oncol. 2002. PMID: 11996473 Free article. Clinical Trial.
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
Sculier JP, Paesmans M, Bureau G, Dabouis G, Libert P, Vandermoten G, Van Cutsem O, Berchier MC, Ries F, Michel J, et al. Sculier JP, et al. Among authors: michel j. J Clin Oncol. 1993 Oct;11(10):1858-65. doi: 10.1200/JCO.1993.11.10.1858. J Clin Oncol. 1993. PMID: 8410110 Clinical Trial.
HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.
Di Leo A, Larsimont D, Gancberg D, Jarvinen T, Beauduin M, Vindevoghel A, Michel J, Focan CH, Ries F, Gobert PH, Closon-Dejardin MT, Dolci S, Rouas G, Paesmans M, Lobelle JP, Isola J, Piccart MJ. Di Leo A, et al. Among authors: michel j. Ann Oncol. 2001 Aug;12(8):1081-9. doi: 10.1023/a:1011669223035. Ann Oncol. 2001. PMID: 11583189 Free article. Clinical Trial.
2,628 results